BB
Therapeutic Areas
Turn Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GX-03 | Moderate-to-Severe Atopic Dermatitis (Eczema) | Phase 1 |
| Hexagen™ Wound Dressing | Wound Care & Infection Prevention | Commercial |
| Thermostable Vaccine Initiative | Global Health / Infectious Disease | Research |